SureTrader
Home > Boards > US OTC > Medical - Drugs >

Cellceutix Corporation (CTIX)

CTIX RSS Feed
Add CTIX Price Alert      Hide Sticky   Hide Intro
Moderator: BigKahuna, BooDog, TOB, sox040713, Astavakra, TheHound
Search This Board:
Last Post: 8/25/2016 5:54:35 PM - Followers: 707 - Board type: Free - Posts Today: 61

Cellceutix Corporation (CTIX)
 

 

http://cellceutix.com/
 
Company Address:
100 Cumming Center, Suite 151-B
Beverly, MA 01915
Phone: 978-236-8717
Fax:  978-921-6564
Email:  info@cellceutix.com
 
About Cellceutix: 

Headquartered in Beverly, Massachusetts, Cellceutix is a publicly traded company under the symbol “CTIX”. Cellceutix is a clinical stage biopharmaceutical company developing innovative therapies in multiple diseases. Cellceutix believes it has a world-class portfolio of compounds and is now engaged in advancing its compounds and seeking strategic partnerships. Cellceutix’s anti-cancer drug Kevetrin concluded a Phase 1 clinical trial at Harvard Cancer Centers’ Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center, and Cellceutix is now preparing its FDA application for a Phase 2 ovarian cancer study. In the laboratory, Kevetrin has shown to induce activation of p53, often referred to as the “Guardian Angel Gene” due to its crucial role in controlling cell mutations. Cellceutix is in a Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention of Oral Mucositis in patients with head and neck cancer. Brilacidin-OM, a defensin mimetic compound, has shown in an animal model to reduce the occurrence of severe ulcerative oral mucositis by more than 94% compared to placebo. Cellceutix’s anti-psoriasis drug Prurisol completed a Phase 2 trial. Prurisol is a small molecule that acts through immune modulation and PRINS reduction. Cellceutix’s lead antibiotic, Brilacidin, has completed a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infections, or ABSSSI. Top-line data have shown a single dose of Brilacidin to deliver comparable clinical outcomes to the FDA-approved seven-day dosing regimen of daptomycin. Brilacidin has the potential to be a single-dose therapy for certain multi-drug resistant bacteria (Superbugs). Brilacidin is also being evaluated in a Phase 2 Proof-of-Concept trial as a novel treatment for Ulcerative Proctitis. Cellceutix has formed research collaborations with world-renowned research institutions in the United States and Europe, including MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna. More information is available on the Cellceutix web site at www.cellceutix.com. 

Management:  http://cellceutix.com/team/

Ongoing Human Trials:  http://clinicaltrials.gov/ct2/results?term=Cellceutix+Pharmaceuticals&Search=Search
 
Product Pipeline:  http://cellceutix.com/pipeline/

 

 
Recent News and Press Releases: 
http://finance.yahoo.com/q/h?s=CTIX+Headlines

Seeking Alpha focus articles on CTIX: http://seekingalpha.com/symbol/CTIX
 
http://cellceutix.com/category/press-release/

A randomized, double-blind study comparing single-dose and short-course brilacidin to daptomycin in the treatment of acute bacterial skin & skin structure infections (ABSSSI)

http://eccmid.meetingexpert.net/ECCMID_546/poster_122533/program.aspx/anchor122533

Synthetic novel host defense protein mimetics for the treatment of Gram-negative bacterial infections

http://eccmid.meetingexpert.net/ECCMID_546/poster_122353/program.aspx

 
SEC Filings (CIK:0001355250):  http://www.sec.gov/cgi-bin/browse-edgar?company=Cellceutix+Corp&match=&CIK=ctix&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f
cs@wcsti.com
http://www.westcoaststocktransfer.com/

 
Share Structure:  See SEC filing link above for current share structure
 

Cellceutix IP - Patent Filings:

EPO
http://worldwide.espacenet.com/searchResults?PA=Cellceutix&DB=EPODOC&locale=en_EP&ST=advanced&compact=false
WIPO
http://www.wipo.int/patentscope/search/en/detail.jsf?docId=WO2010135170&recNum=1&docAn=US2010034838&queryString=FP:(Cellceutix)&maxRec=1
USPTO
http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=0&f=S&l=50&TERM1=Cellceutix&FIELD1=AS&co1=AND&TERM2=&FIELD2=&d=PG01 


http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,796,275.PN.&OS=PN/8,796,275&RS=PN/8,796,275

 

Publication number US8338454 B2
Publication type Grant
Application number US 12/780,132
Publication date Dec 25, 2012
Filing date May 14, 2010
Priority date May 20, 2009
Also published as CA2762427A1, CN102438612A, EP2432464A2, US20100298374, US20130245062, WO2010135170A2, WO2010135170A3, Less «6 More »
Publication number 12780132, 780132, US 8338454 B2, US 8338454B2, US-B2-8338454, US8338454 B2, US8338454B2
Inventors Krishna Menon
Original Assignee Cellceutix Corporation
Export Citation BiBTeX, EndNote, RefMan
Patent Citations (6), Non-Patent Citations (41), Referenced by (1), Classifications (42)
 
External Links: USPTO, USPTO Assignment, Espacenet


http://www.google.com/patents/US8338454

http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=6&f=G&l=50&co1=AND&d=PG01&s1=Cellceutix.AS.&OS=AN/Cellceutix&RS=AN/Cellceutix

 
Investor Relations:  info@cellceutix.com

Following is a WEEKLY chart:


 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
 
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
 
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CTIX
Current Price
Volume:
Bid Ask Day's Range
SureTrader
CTIX News: Insider Financial Publishes New Research On Three Promising Biotechs 07/16/2016 08:00:00 AM
CTIX News: Securities Registration: Employee Benefit Plan (s-8) 07/15/2016 04:52:11 PM
CTIX News: Securities Registration: Employee Benefit Plan (s-8) 07/15/2016 04:50:06 PM
CTIX News: Current Report Filing (8-k) 07/14/2016 08:11:43 AM
CTIX News: Statement of Changes in Beneficial Ownership (4) 07/11/2016 01:03:04 PM
PostSubject
#156616  Sticky Note Interview With New Cellceutix President Dr A Bertolino BigKahuna 08/11/16 11:49:13 PM
#156603  Sticky Note CTIX Interviews, Potential Catalysts and Past Milestones sox040713 08/11/16 06:13:05 PM
#156101  Sticky Note Cellceutix Prepares Phase 2a Ovarian Cancer Trial of DaubersUP 08/03/16 09:32:39 AM
#155690  Sticky Note Risk vs Volatility - I've been quietly watching BioHedge 07/26/16 12:34:09 AM
#155456  Sticky Note Cellceutix Expedites Phase 2 Trial of Brilacidin-OM For wild4ctix 07/21/16 07:15:58 AM
#117003  Sticky Note Cellceutix released efficacy data for Kevetrin, its cancer TOB 08/09/15 03:05:24 PM
#157533   Too bad. I sold at 99.00 septmike09 08/25/16 05:54:35 PM
#157531   well there goes you $800 change in investment cascott 08/25/16 05:19:59 PM
#157530   Bullshit. sold at 1.37 BigKahuna 08/25/16 05:06:08 PM
#157528   All 80K? tombrady12nh 08/25/16 04:57:08 PM
#157526   that goes double for me! cascott 08/25/16 04:55:18 PM
#157521   sold at 1.37 MXAMDUD 08/25/16 04:10:21 PM
#157520   There was only one instance the tape hit rule_rationale 08/25/16 04:09:13 PM
#157518   Yeah, we got our daily penny. On wards septmike09 08/25/16 04:01:01 PM
#157517   bought some more at 1.33 MXAMDUD 08/25/16 03:59:50 PM
#157516   Enormous multiples of 10 share trades! Wow. I rule_rationale 08/25/16 03:17:46 PM
#157515   stock getting hit again with big sells MXAMDUD 08/25/16 03:08:27 PM
#157514   yeah - glory days were when the stock MXAMDUD 08/25/16 02:53:45 PM
#157513   Maybe you have not noticed how the stock SJ2016 08/25/16 02:26:22 PM
#157512   that's funny stuff MXAMDUD 08/25/16 02:24:26 PM
#157509  Restored For sure. I'd settle for being a Detonate 08/25/16 01:16:55 PM
#157508   I know....it's so strange from being here for DaubersUP 08/25/16 01:12:59 PM
#157507  Restored 30k shares and rising. Unlike you, I believe flaboy2963 08/25/16 12:51:26 PM
#157506   Very interesting. Have you sent that to F1ash 08/25/16 12:50:24 PM
#157505   Someone really wants shares, stock is being accumulated big-time. SJ2016 08/25/16 12:48:45 PM
#157504   stock getting pounded again. 28k block just MXAMDUD 08/25/16 12:43:31 PM
#157501   I wonder if Leo is itching to release septmike09 08/25/16 12:36:08 PM
#157498   Yes this is a job for an MDM2 frrol 08/25/16 11:54:06 AM
#157497   MX Happens in growth stocks . Echo20 Echo20 08/25/16 11:48:45 AM
#157496   Running girl Good point for K and p53 for Echo20 08/25/16 11:46:53 AM
#157495   Interesting P53 article runninggirl2016 08/25/16 11:25:53 AM
#157494   Has this been confirmed with the CTIX Sales Department? Detonate 08/25/16 10:49:35 AM
#157493   Retire in prosperity? scottsmith 08/25/16 10:40:30 AM
#157492   Mxamdud, your daily analysis is invaluable. A giant taas 08/25/16 10:39:20 AM
#157491   The only reason for the sector downturn is SJ2016 08/25/16 10:32:38 AM
#157490   nope MXAMDUD 08/25/16 10:22:25 AM
#157489   Tomorrow, Tomorrow, I love you Tomorrow. MXAMDUD 08/25/16 10:22:11 AM
#157488   CTIX=RIP MXAMDUD 08/25/16 10:09:27 AM
#157487   75%'ish would be my guess too. Massive Relentless4ever 08/25/16 10:06:45 AM
#157486   Georgejjl My guess is 75% or more. runninggirl2016 08/25/16 09:58:34 AM
#157485   Oh boy frrol 08/25/16 08:34:16 AM
#157484   Hmmm CTIX has been quiet. I like tombrady12nh 08/25/16 08:33:57 AM
#157483   I hope they succeed. Company's profile is low frrol 08/25/16 08:30:43 AM
#157480   I believe his stated goal was to generate scottsmith 08/25/16 07:59:53 AM
#157479   I wonder how Leo's road show turned out. nerby 08/25/16 07:56:16 AM
#157478   Approximately 33% of all subjects with psoriasis have georgejjl 08/25/16 07:37:46 AM
#157477   GZTY-I have all I can afford-been waiting for tombrady12nh 08/25/16 07:25:36 AM
#157476   I am not waiting for the results. I georgejjl 08/25/16 07:24:10 AM
#157475   All we can do is wait for results George. tombrady12nh 08/25/16 07:22:32 AM
#157474   ANSWER THIS QUERY georgejjl 08/25/16 07:18:59 AM
#157473   CTIX-0002 – Phase 2 Topline Clinical Trial Results georgejjl 08/25/16 07:11:16 AM
#157472   Patent applications georgejjl 08/24/16 08:28:11 PM
#157471   Got plenty, and time to spare, as they Ringrock 08/24/16 08:13:17 PM
#157470   FINRA short sales of CTIX AlanC 08/24/16 08:04:57 PM
#157469   Yes it is. They can't push the launch TheHound 08/24/16 06:25:50 PM
#157468   IBB down 3%, CTIX up 1%. I TheHound 08/24/16 06:19:11 PM
PostSubject